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The relationship between diabetes mellitus and hearing 
loss is described as ‘controversial’ in the literature, given 
that in the clinical realm many patients present dysacusis 
while others do not. Aim: this study aims to investigate 
the relationship between hearing loss and diabetes mellitus 
and add to the knowledge being developed in this area. 
Study design: cross-sectional clinical trial. Materials and 
method: in our study we analyzed the medical charts of 50 
adult patients of both genders, aged above 45 years, and 
diagnosed with diabetes mellitus, seen in our institution 
in 2006 and 2007, and compared them to the charts of 50 
metabolic disease-free individuals. Results: this study found 
statistically significant worse audiometric thresholds among 
patients with diabetes mellitus when compared to patients 
in the control group. Conclusion: the results identified in 
this study point to a correlation between hearing loss and 
diabetes mellitus. This possibility should therefore be further 
investigated by health care workers providing care to patients 
with diabetes mellitus, in the form of closer follow-up on the 
auditory health of this patient group.
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INTRODUCTION
Diabetes mellitus (DM) is a genetically inherited 
disease in which glucose serum levels are abnormally high 
due to relative or absolute insulin deficiency. Its clinical 
manifestation is characterized by metabolic disorders, and 
vascular and neuropathic complications. DM is yet an 
incurable disease and its management should be focused 
on preventing chronic complications1.
Diffuse thickening of basal membranes, also obser-
ved in the vascular endothelium, is one of the most pre-
valent morphologic findings in DM, referred to as diabetic 
microangiopathy. Such thickening is more evident on skin 
capillaries of skeletal muscles, retina, kidney glomeruli, 
and renal medulla. The pathogenesis of this morphologic 
disorder is yet unclear, but it is directly related to hyper-
glycemia. There also are morphologic disorders related to 
the involvement of lower extremity motor and sensorial 
nerves, characterized by injuries to Schwann cells, myeli-
nic degeneration, and axonal damage. The cause of this 
neuropathy is still controversial, but it may be related to 
diffuse microangiopathy and the consequent malnourish-
ment of peripheral nerves. Arteriosclerosis, frequently 
seen in conjunction with DM, may also contribute to the 
onset of neuropathies, as it interferes with the nutrient 
transfer rate2,3.
Angiopathy may occur both directly - interfering 
with cochlear blood supply and reducing nutrient trans-
portation as a result of capillary wall thickening - and 
indirectly - reducing flow in a narrowed vasculature or, 
yet, causing secondary degeneration of the eighth cranial 
nerve4.
Studies carried out on rats found thickened walls 
in the vessels of the modiolus, increased basal membrane 
thickness in the stria vascularis capillaries and increased 
loss of outer hair cells (this last feature was found in dia-
betic rats exposed to noise). These studies were disputed, 
as drugs were given to the rats to induce DM, thus not 
reflecting the actual physiological and genetic mechanism 
that leads to the onset of DM in human beings5-8.
Pathology tests carried out in temporal bones of 
diabetic individuals of various age ranges have shown that 
the changes in stria vascularis capillary wall thickness - 
they were 10 to 20 times thicker than usual - were similar 
to those found in atherosclerosis, although they were 
more pronounced and limited to the stria vascularis. The 
authors have also observed other forms of degeneration, 
but they were also seen in temporal bones of non-diabetic 
individuals of the same age ranges. They also reported that 
these alterations are typically found in DM patients, but 
that they are not DM-specific, observing that atheroscle-
rosis is reduced peripherally, whereas diabetic angiopathy 
increases in intensity in small vessels9.
Another study performed on temporal bones de-
tected thickened stria vascularis and modiolus capillary 
thickening5.
Capillary wall thickening and the consequently re-
duced vessel lumen will more intensely affect the internal 
auditory artery3.
Other pathology test-based studies done in humans 
described spiral ganglion neuron atrophy and eighth 
cranial nerve demyelination in diabetic individuals, indi-
cating that demyelination is also an early injury to extre-
mity peripheral nerves in DM and that myelin metabolic 
disorders may be relevant in the pathogenesis of diabetic 
neuropathy. The following findings were observed un-
der optic microscopy: auditory nerve demyelination by 
degeneration of the myelin sheath, with minor axonal 
alterations and perineurium fibrosis; severe spiral ganglion 
atrophy with cell loss in the cochlear basal and middle 
turns, accompanied by decreased number of nerve fibers 
in the spiral lamina. Other findings are: reduced number 
of ganglion cells in the ventral and dorsal cochlear nuclei, 
small loss of ganglion cells in the superior olivary com-
plex, inferior colliculus and medial geniculate body. No 
DM-specific alteration was found in the auditory centers 
of either temporal lobes3.
Some authors believe that angiopathy is the primary 
injury connected to hearing loss, while others credit such 
role to neuropathy, arguing that vessel wall thickening is 
quite unspecific and also found in other diseases. Human 
audiology studies indicate that the thresholds of patients 
with peripheral neuropathy were always worse than con-
trol group individuals in any frequency10.
Hearing loss may also have its origins in congenital 
or acquired genetic mutations affecting nuclear and mi-
tochondrial genes in both syndromic and non-syndromic 
manifestations8. Mitochondrial DNA mutations are trans-
mitted through maternal genes, but spontaneous mutations 
may also occur. Mitochondrial disorders may lead to cell 
death11,12.
In a study done on a particular genogram in which 
nine children of mothers with DM also developed the 
disease, coinciding hearing loss of varied severity was 
observed in each diabetic individual. The authors also 
observed that in the third generation of this family dia-
betes and hearing loss were present only in the offspring 
of affected mothers. Such finding strongly suggested that 
inheritance is exclusively maternal, a trait found in diseases 
associated with mitochondrial DNA mutation13.
Other studies reported that DM may be part of a 
genetically inherited syndrome in which diabetes melli-
tus is merely one of the syndrome’s symptoms: Wolfram 
syndrome, also called DIDMOAD (Diabetes Insipidus, 
Diabetes Mellitus, Optic Atrophy and Deafness)14.
Some authors have mentioned DM as a possible 
cause for sudden hearing loss. In spite of other causing 
factors such as atherosclerosis and viral infection, DM is 
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seen as the main cause of deafness due to diabetic mi-
croangiopathy15.
Many papers have tried to identify the relationship 
between hearing loss and DM. Such studies are justified 
as controversy still looms this topic, and given that while 
many diabetic patients develop hearing loss, many do not. 
Another fact is that most of the time DM will involve older 
patients, thus making it even harder to connect hearing 
loss to DM due to presbycusis.
A study compared 51 diabetic patients aged betwe-
en 8 and 21 years against a control group of 13 patients 
and found no statistically significant differences between 
their audiological test results16.
However, contradictory results were found in 
other studies on the same topic. Another study looked 
at 30 diabetic patients and compared them to 30 healthy 
individuals, all of which aged 50 or more, only to find 
higher prevalence rates of high frequency hearing loss 
among diabetic patients. No connections were however 
established between hearing loss and disease duration17. 
There is also a study that correlates hearing loss and di-
sease duration, without however setting clear criteria to 
pick participants of the control group, thus questioning 
the validity of its findings18.
Other studies suggest that there could be injuries in 
various points of the auditory pathways, possibly due to 
neural defects or cochlear injury. Results indicate that the 
hearing loss patterns found in DM patients do not comply 
with what is observed in senility-related hearing loss in 
terms of frequency distribution10.
Another study found high-frequency sensorineural 
hearing loss in 37.5% in the patient population. However, 
these results were not compared against a control group19.
This paper aims to describe the audiological cha-
racteristics of diabetes mellitus patients and compare these 
findings against to the test results of DM-free individuals 
of similar age groups.
MATERIALS AND METHOD
This study was carried out in the Clinical Audiology 
Division of a health care center located in the countryside 
of the State of São Paulo, Brazil. The study was approved 
by the Research Ethics Committee of our institution under 
permit 1494/2006.
The medical charts of 50 diabetes mellitus patients 
of both genders (66% females and 34% males) aged 
between 45 and 83 years (mean 67.56 years) sent for 
audiological examination in the years of 2006 and 2007 
were examined17.
We collected information on the patients’ audiologi-
cal history, identification data and hearing health history; 
tone threshold audiometry, to assess tone thresholds (air 
and bone conduction)21; logoaudiometry, to evaluate spe-
ech recognition index (SRI) or speech reception threshold 
(SRT)21; impedance test, to analyze tympanometry and 
acoustic reflex data of the stapedius muscle (these proce-
dures looked at the functional integrity of the ossicular-
tympanic complex)22.
Audiometry and logoaudiometry tests were per-
formed in a soundproof booth, with audiometer GSI 61 
Grason - Stadler. Acoustic impedance test measurements 
were performed with a GSI 38 Grason - Stadler device.
The data sets were analyzed in terms of audiometric 
findings: hearing loss level23,24. Logoaudiometry provided 
the data required to confirm the audiometry findings to 
assist in topographic diagnosis21. ANOVA25 was used to 
verify statistically significant differences between the mean 
hearing threshold values.
Tympanometry results were classified as proposed 
by Jerger26 and acoustic reflex was analyzed as present 
or absent.
RESULTS
The main results obtained from audiological re-
search in the group of DM patients were the following: 
dysacusis (74%), high blood pressure (72%), tinnitus (70%), 
recruitment (46%), aural fullness (44%), otalgia (36%), 
dizziness (32%), autophony (30%), vertigo (30%), pruritus 
(24%), and oozing (4%). The main findings gathered from 
the control group were: dysacusis (50%), tinnitus (46%), 
recruitment (30%), aural fullness (24%), vertigo (22%), 
autophony (14%), otalgia (14%), dizziness (14%), and 
oozing (4%).
No statistically significant differences were found 
between the age mean values and standard deviations 
for the case (65.50±8.48) and control 67.56±9.55) groups 
(Anova p=0.256 / a=0.05).
In the case group, acoustic reflex was present in 
72% and absent in 28% of the patients. Acoustic reflex was 
present in 41% and absent in 59% of the control group 
subjects.
Tone audiometry tests identified the following types 
of hearing loss among case group members: sensorineural 
(38%), mixed (24%), and conductive (1%); 37% of the au-
diograms in this group were considered as normal. Control 
group members had the following types of hearing loss: 
sensorineural (26%), mixed (4%), and conductive (2%); 
68% of the audiograms in this group were deemed normal.
In order to facilitate analysis, the results for impe-
dance tests and hearing loss levels are presented in the 
form of tables considering each analyzed variable.
Table 1 presents the data on impedance tests perfor-
med on DM patients compared against the data gathered 
from control group individuals (100 ears for each group).
Table 2 compares the audiometry test results con-
sidering the differences in mean values between the case 
and control groups.
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Table 3 shows data on the comparison between 
the two types of classification schemes used in this study 
(Davis & Silvermann23 and Recommendation 02/1 from the 
Bureau International d’Audio Phonologie - BIAP24) within 
each of the groups.
Tables 4 and 5 contain the analysis on the level 
of hearing loss for the case group, while Tables 6 and 
7 contain the same data however for the control group.
Table 1. Impedance test results for the control group (CG) compa-
red against the diabetes mellitus group (DM); analysis of 100 ears 
from each group.
 CG DM
A 88% 80%
B 2% 10%
Ad 6% 6%
As 4% 4%
Table 2. Statistical analysis results; audiometric thresholds (dB) 
mean values and standard deviation according to Davis & Silver-
mann24 (DS) and BIAP25 for the two groups - control group (CG) vs. 
diabetes mellitus group (DM).
 CG DM Anova p value
BIAP RE 24.82±12.28 38.25±21.36 0.000208a
BIAP LE 24.17±12.67 39.40±20.96 0.000028a
DS RE 21.88±11.68 35.18±20.55 0.000133a
DS LE 20.76±12.44 35.80±19.53 0.000013a
a significant for a = 0.001
Table 3. Statistical analysis results; audiometric thresholds (dB) 
mean values and standard deviation, Davis & Silvermann24 (DS) vs. 
BIAP25, for the two groups - control group (CG) vs. diabetes mellitus 
group (DM).
 BIAP DS Anova p value
GC RE 24.82±12.28 21.88±11.68 0.222a
GC LE 24.17±12.67 20.76±12.44 0.176a
DM RE 38.25±21.36 35.18±20.55 0.465a
DM LE 39.40±20.96 35.80±19.53 0.376a
a non-significant for a = 0.05
Table 4. Audiometric test results for right and left ears; patients in 
the diabetes mellitus group, according to hearing loss level - Davis & 
Silvermann24.
Level
Right ears Left Ears Total
n % n % n %
Normal 20 40 16 32 36 36
Mild 8 16 18 36 26 26
Moderate 21 42 15 30 36 36
Severe 1 2 1 2 2 2
Table 5. Audiometric test results for right and left ears; patients in 
the diabetes mellitus group, according to hearing loss level - BIAP25
Level
Right ears Left Ears Total
n % n % n %
Normal 14 28 12 24 26 26
Mild 12 24 12 24 24 24
Moderate grade 1 11 22 15 30 26 26
Moderate grade 2 11 22 8 16 19 19
Severe grade 1 2 4 2 4 4 4
Severe grade 2 - - 1 2 1 1
Table 6. Audiometric test results for right and left ears; patients in 
the control group (DM-free subjects) according to hearing loss level 
- Davis & Silvermann24.
Level
Right ears Left Ears Total
N % n % n %
Normal 36 72 34 68 70 70
Mild 11 22 12 24 23 23
Moderate 6 6 4 8 7 7
Table 7. Audiometric test results for right and left ears; patients in 
the control group (DM-free subjects) according to hearing loss level 
- BIAP25.
Level
Right ears Left Ears Total
N % n % n %
Normal 21 42 24 48 45 45
Mild 25 50 20 40 45 45
Moderate 
grade 1
4 8 6 12 10 10
DISCUSSION
Tone audiometry test results were significantly 
worse among diabetic patients when compared to con-
trol group individuals from the statistical standpoint, thus 
577
Brazilian Journal of otorhinolaryngology 75 (4) July/august 2009
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
eliciting a correlation between DM and hearing loss in 
our group of subjects27. Audiometry test results were 
also statistically compared after being categorized by 
two different methods3,24, but no statistically significant 
difference was found between the two quantitative clas-
sification approaches. Qualitatively, however, there was 
an increase on the number of subjects with normal mean 
speech frequency when Davis & Silvermann23 was used 
in comparison to BIAP24.
According to Jerger26, tympanometric A-curves are 
found in individuals with normal middle ears, while As-
curves refer to stiff tympanic-ossicular systems, and Ad-
curves show tympanic-ossicular system laxity. B-curves are 
present in individuals with fluid in their middle ears, and 
C-curves are related to Eustachian tube disorders.
A-curves were found in 80% of the DM group mem-
bers and in 88% of the control group subjects, as they can 
be related to normal hearing and sensorineural hearing 
loss. This finding matches the main type of hearing loss 
diagnosed in our study (sensorineural). The number of 
B, Ad, and As-curves in the DM group was higher when 
compared to the control group, as more mixed and con-
ductive hearing loss cases were also seen in the case group.
Acoustic reflex is an involuntary contraction of the 
stapedius muscle in response to sound stimuli. Normal 
threshold values range between 70 and 100 dB, and are 
situated usually 85 dB above the hearing threshold21. This 
was found in 28% of the DM patients and in 41% of the 
subjects in the control group. Apart from hearing losses, 
conductive components also account for the differences 
found between the groups, as a greater number of mixed 
and conductive were found in the DM group21.
The widespread presence of high blood pressure 
in this population points to angiopathy as one of the 
main etiologies, as described by Robbins2, Makishima3 
and Taylor4.
No statistically significant differences were found 
in the mean ages of the DM and control group members, 
as described by Frisina28 and Sasso29.
The data gathered from the audiological interview 
indicated that the main complaint from DM group mem-
bers was dysacusis, followed by high blood pressure, 
and tinnitus. Fukui15 identified diabetes, hearing loss, 
high blood pressure, and tinnitus as the main clinical 
factors manifested by DM patients. Such finding matched 
audiometry test results, as they revealed a predominance 
of bilateral sensorineural hearing loss30. Such prevalence 
of bilateral sensorineural hearing loss may be related to 
hyperglycemia, i.e., a systemic disease that results in bila-
teral disorders. Tympanometric curves and acoustic reflex 
findings were compatible with tone audiometry results.
A paper published recently showed similar findin-
gs, indicating that DM is associated with hearing loss in 
middle-aged individuals. This paper is the only that seems 
to present such association at a larger scale27.
CONCLUSION
The findings and results gathered in this study point 
to the existence of a relationship between hearing loss and 
diabetes mellitus. Therefore, the auditory health of DM 
patients is to be more carefully and thoroughly followed 
up by health care workers dealing with this condition.
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